# A Clinical Study of MK-1045 (CN201) in People With Precursor B-cell Acute Lymphoblastic Leukemia (MK-1045-002)

> **NCT05579132** · PHASE1,PHASE2 · RECRUITING · sponsor: **MSD R&D (China) Co., Ltd.** · enrollment: 203 (estimated)

## Conditions studied

- Acute Lymphoblastic Leukemia

## Interventions

- **DRUG:** MK-1045

## Key facts

- **NCT ID:** NCT05579132
- **Lead sponsor:** MSD R&D (China) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-11-01
- **Primary completion:** 2028-06-30
- **Final completion:** 2028-06-30
- **Target enrollment:** 203 (ESTIMATED)
- **Last updated:** 2026-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05579132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05579132, "A Clinical Study of MK-1045 (CN201) in People With Precursor B-cell Acute Lymphoblastic Leukemia (MK-1045-002)". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05579132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*